Skip to main content

Find Clinical Trials

Home
Conditions
Motor Neuron Disease

Clinical trial condition

Motor Neuron Disease

Explore clinical trials studying Motor Neuron Disease. Study availability and eligibility vary by location and protocol.

839 public trials 197 recruiting studies

Refine in advanced search Browse all conditions

Motor Neuron Disease trial results

Not Yet Recruiting

The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

NCT07688239

Conditions: ALS, ALS (Amyotrophic Lateral Sclerosis), ALS - Amyotrophic Lateral Sclerosis, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec

NCT07444450

Conditions: Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Auto-calibrating System for Upper Limb Disability Assessment, Neurological and Occupational Rehabilitation

NCT07636538

Conditions: Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases, Brain Diseases, +24 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I

NCT07554924

Conditions: Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

Children's Hospital of Fudan University Shanghai, Shanghai Municipality, China

Children's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Exploring Lived Experiences of Families of Children With Spinal Muscular Atrophy(SMA) Type 1 Regarding Feeding and Communication

NCT07596277

Conditions: Behavior, Central Nervous System Diseases, Communication, +20 more
Locations: GSTT Evelina Neurosciences London, United Kingdom

View Trial Details

Not Yet Recruiting

ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)

NCT07448610

Conditions: Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluation of the Impact of Virtual Park on Training Motivation in Adult Patients

NCT07616050

Conditions: Amyotrophic Lateral Sclerosis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +30 more
Locations: Istituti a Carattere Scientifico Maugeri Bari Bari, Italy

Istituti a Carattere Scientifico Maugeri Telese Telese Terme, Benevento, Italy

Centro di Riabilitazione Villa Beretta Costa Masnaga, Lecco, Italy

Istituti a Carattere Scientifico Maugeri Milano Camaldoli Milan, Milano, Italy

View Trial Details

Not Yet Recruiting

Transcutaneous Superior Laryngeal Nerve Stimulation to Upregulate Swallowing Frequency and Urge to Swallow in Patients Living With ALS

NCT07606235

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Research of Traditional Chinese Medicine Oral Preparation of C. Cicadae in the Treatment of ALS Patients With Elevated Plasma Sphingolipids

NCT07467746

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Widely Inclusive, Hybrid-Decentralized Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS

NCT07589764

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis ALS, Central Nervous System Diseases, +9 more
Locations: Duke University Medical Center Durham, North Carolina, United States

Temple University Philadelphia, Pennsylvania, United States

View Trial Details